Pain Relief Patch CAMPHOR, METHYL SALICYLATE, MENTHOL 3.1 g; 6 g; 10 g Patch, 60 patches — NDC 83324-255-60 (Billing 83324-0255-60)
This is a package of 60 patches of Pain Relief Patch CAMPHOR, METHYL SALICYLATE, MENTHOL 3.1 g; 6 g; 10 g Patch from CDMA, Inc., marketed since Jul 2025 and currently FDA-listed. It is this product's only package size.
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 1793147
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
This is an over-the-counter topical patch containing camphor, menthol, and methyl salicylate. These ingredients are commonly used in pain-relief products applied to the skin. Camphor and menthol typically produce a warming or cooling sensation, while methyl salicylate is a salicylate compound often included in topical pain-relief formulations. The patch is designed to be applied directly to the skin over the area of discomfort.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 3, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 83324-0255-60 You're viewing this Main listing | 60 PATCH in 1 PACKAGE | 2025-07-01 | — | Active |
Therapeutic equivalents
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Sep 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 39EYQ1W9RB
A synthetic oil made from hydrogenated plant or petroleum waxes. It serves as a lubricant and glidant in tablet or capsule formulations to reduce friction during manufacturing and improve powder flow.
-
UNII 6ZAE7X688J
A refined mineral oil derived from crude petroleum. It serves as a lubricant and binder in tablet and capsule formulations, helping medicines slide smoothly through manufacturing equipment and improving how ingredients stick together.
-
UNII 255PIF62MS
A synthetic antioxidant compound used to prevent oils and fats in medications from breaking down or becoming rancid during storage. It helps maintain the medicine's stability and shelf life.
-
UNII H58HX2GWJ5
A synthetic rubber made from styrene and isoprene monomers. It serves as a film-former and binder in tablet coatings and sustained-release formulations to control how quickly the medicine dissolves and releases.
4 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses Temporary relief of minor aches and pains of muscles and joints: arthritis, simple backache, muscle strains, muscle sprains, and bruises.
⏱️ Dosage and Administration ▾
Directions Adults and children 12 years of age and over: Clean and dry affected area, free of lotions, ointments and creams. Remove patch from film, apply to affected area. Do not use more than one patch in an 8 hour period. Repeat as necessary. Maximum 3 patches per day. Discard patch after single use. Reseal pouch after opening. Children under 12 years of age: Consult a physician.
⚠️ Warnings ▾
Warnings For external use only. Allergy alert: If prone to allergic reaction from aspirin or salicylates, consult a doctor before use.
📦 Storage and Handling ▾
Other Information Store in a clean, dry place outside of direct sunlight. Protect from excessive moisture.
🧪 Active Ingredient ▾
Active Ingredients Camphor 3.1% - Topical analgesic Menthol 6.0% - Topical analgesic Methyl Salicylate 10.0% - Topical analgesic
🧪 Inactive Ingredients ▾
Inactive Ingredients Hydrogenated poly Pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate Petroleum Styrene/isoprene copolymer
🎯 Purpose ▾
Purpose Topical analgesic
📄 Do Not Use ▾
Do not use more than one patch on your body at a time, on wounds or damaged skin, with a heating pad, or if you are allergic to any ingredients of this product.
📄 When Using This Product ▾
When using this product: Use only as directed, avoid contact with eyes, mucous membranes or rashes, do not bandage tightly, do not use at the same time as other topical analgesics.
📄 Stop Use and Ask a Doctor If ▾
Stop use and consult a doctor if rash, itching or excessive skin irritation develops, condition worsens, symptoms last more than 7 days or clear up and occur again within a few days.
🤰 If Pregnant or Breast-Feeding ▾
If pregnant or breastfeeding, ask a health professional before use.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
📄 Package Label / Principal Display Panel ▾
Label
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |